Evidence for μ1-opioid receptor involvement in fentanyl-mediated respiratory depression

European Journal of Pharmacology

Volumn 312, Issue 2, 1996, Pages 241-244

  Chen, Shu Wen ^a   Maguire, Patricia A ^a   Frances Davies, M ^a   Beatty, Mark F ^b   Loew, Gilda H ^a  

^a MOLECULAR RESEARCH INSTITUTE   (United States)

^b University of Bath   (United Kingdom)

Author keywords

Fentanyl; Morphine; Muscle rigidity; Respiratory depression; 1 opioid receptor

Indexed keywords

FENTANYL; FENTANYL DERIVATIVE; MORPHINE; MU OPIATE RECEPTOR; NALOXONAZINE; CARBON DIOXIDE; DRUG DERIVATIVE; NALOXONE; OXYGEN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; ANIMAL; BLOOD; BREATHING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY FAILURE;

ANIMALS; CARBON DIOXIDE; FENTANYL; NALOXONE; OXYGEN; RATS; RECEPTORS, OPIOID, MU; RESPIRATION; RESPIRATORY INSUFFICIENCY;

EID: 0030603161     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00571-7     Document Type: Article

References (12)

1. Bagley, J.R., R.L. Wynn, F.G. Rudo, B.M Doorley, H.K. Spencer and T. Spaulding, 1989, New 2-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties, J. Med. Chem. 32, 663.
2. Chen, J.-C., E.R. Smith, M. Cahill, R. Cohen and J.B. Fishman, 1993, The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine, Life Sci. 52, 389.
3. Ling, G.S.F., K. Spiegel, S.L. Nishimura and G.W. Pasternak, 1983, Dissociation of morphine's analgesic and respiratory depressant actions, Eur. J. Pharmacol. 86, 487.
4. Ling, G.S.F., K. Spiegel, S.H. Lockhart and G.W. Pasternak, 1985, Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms, J. Pharmacol. Exp. Ther. 232, 149.
5. Ling, G.S.F., R. Simantov, J.A. Clark and G.W. Pasternak, 1986, Naloxonazine actions in vivo, Eur. J. Pharmacol. 129, 33.
6. Negus, S.S., E.R. Butelman, K.-J. Chang, B. DeCosta, G. Winger and J.H. Woods, 1994, Behavioral effects of the systematically active delta opioid agonist BW373U86 in rhesus monkeys, J. Pharmacol. Exp. Ther. 270, 1025.
7. Paakkari, P., I. Paakkari, A.-L. Siren and G. Feuerstein, 1990, Respiratory and locomotor stimulation by low doses of dermorphin, a mul receptor-mediated effect, J. Pharmacol. Exp. Ther. 252, 235.
8. 1-receptors, J. Pharmacol Exp. Ther. 266, 544.
9. Paul, D. and G.W. Pasternak, 1988, Differential blockade by naloxonazine of two μ opiate actions: analgesia and inhibition of gastrointestinal transit, Eur. J. Pharmacol. 149, 403.
10. Pasternak, G.W., 1986, Multiple mu opiate receptors: biochemical and pharmacological evidence for multiplicity, Biochem. Pharmacol. 35, 361.
11. Ward, S.J. and J.W. Holaday, 1982, Relative involvement of mu and delta opioid mechanism in morphine-induced depression of respiration in rats, Soc. Neurosci. Abstr. 8, 388.
12. Ward, S.J. and A.E. Takemori, 1983, Determination of the relative involvement of μ-opioid receptors in opioid-induced depression of respiratory rate by use of β-funaltrexamine, Eur. J. Pharmacol. 87, 1.